Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 3.410
+0.150 (4.60%)
Sep 30, 2025, 4:08 PM HKT
Luye Pharma Group Market Cap
Luye Pharma Group has a market cap or net worth of 13.62 billion as of September 30, 2025. Its market cap has increased by 20.70% in one year.
Market Cap
13.62B
Enterprise Value
18.98B
Revenue
6.76B
Ranking
n/a
PE Ratio
29.50
Stock Price
3.41
Market Cap Chart
Since July 9, 2014, Luye Pharma Group's market cap has increased from 2.95B to 13.62B, an increase of 361.18%. That is a compound annual growth rate of 14.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 13.62B | 66.87% |
| Dec 31, 2024 | 8.16B | -41.82% |
| Dec 29, 2023 | 14.03B | 8.00% |
| Dec 30, 2022 | 12.99B | 3.05% |
| Dec 31, 2021 | 12.61B | 7.49% |
| Dec 31, 2020 | 11.73B | -38.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 214.55B |
| JD Health International | 206.50B |
| WuXi Biologics | 160.93B |
| Innovent Biologics | 160.31B |
| Sino Biopharmaceutical | 144.09B |
| Akeso | 124.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 115.57B |